MAIA SCIENTIFIC - Novel instrumentation for high quality/high content screening

MAIA SCIENTIFIC, a wholly-owned subsidiary of Harvard Bioscience, develops, manufactures and markets novel instrumentation and applications for high quality/high content screening. The MIAS-2 microscopy readers, having both brightfield and fluorescence parameters, and the eaZYX imaging software, utilsing the concept of 'scale space' object-oriented analysis algorithms, offer unprecedented sensitivity, speed and flexibility across the drug discovery and development value chain. The MIAS-2 and eaZYX platforms allow genomics, target validation, assay development, drug discovery and ADMET R&D programs to be conducted on the same platform.

Contract R&D and OEM integration

In close collaboration with its partners, MAIA develops innovative platform technologies, including mechanisation and assay development. The company's assay expertise includes cells, tissues, beads, and small animal organisms. MAIA's software and hardware are applied to create a specialised, customer-oriented product, such as genome research using small model organisms, or pre-clinical and clinical dermatology research.

Products and Services

Contact Details

Tel: +32 (0)14 570 620
Fax: +32 (0)14 570 621

Make An Enquiry
First Name

Last Name

Email Address


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.